| scholarly article | Q13442814 |
| P2093 | author name string | Elizabeth A. Barnes | |
| Heidi L. Kenerson | |||
| Raymond S. Yeung | |||
| Xiuyun Jiang | |||
| P2860 | cites work | Quantitative proteomics identifies a Dab2/integrin module regulating cell migration | Q24311541 |
| Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling | Q24672005 | ||
| Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells? | Q24672066 | ||
| The epithelial-mesenchymal transition: new insights in signaling, development, and disease | Q24683758 | ||
| A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation | Q27617935 | ||
| The tuberin-hamartin complex negatively regulates beta-catenin signaling activity | Q28201617 | ||
| Ksp-cadherin is a functional cell-cell adhesion molecule related to LI-cadherin | Q28250688 | ||
| The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake | Q28512637 | ||
| Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport | Q28565319 | ||
| Molecular genetic advances in tuberous sclerosis | Q33921270 | ||
| Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis | Q34009330 | ||
| The loss of tuberin promotes cell invasion through the ß-catenin pathway | Q34269014 | ||
| Metastasis of benign tumor cells in tuberous sclerosis complex | Q34270994 | ||
| Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. | Q34374170 | ||
| Dysregulation of the TSC-mTOR pathway in human disease | Q34380413 | ||
| Cadherins in neural crest cell development and transformation. | Q34400167 | ||
| Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis | Q34508924 | ||
| Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. | Q34528572 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| Aberrant beta-catenin signaling in tuberous sclerosis | Q35084861 | ||
| Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance | Q35945000 | ||
| The tuberous sclerosis complex genes in tumor development | Q35964423 | ||
| Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients | Q36614440 | ||
| Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. | Q36902961 | ||
| Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival | Q37010522 | ||
| Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis | Q37038088 | ||
| Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis | Q37101089 | ||
| Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region | Q37387858 | ||
| Dynamic microtubules regulate the local concentration of E-cadherin at cell-cell contacts | Q40293778 | ||
| Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat. | Q46840790 | ||
| Regulation of microtubule-dependent protein transport by the TSC2/mammalian target of rapamycin pathway. | Q50730003 | ||
| Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. | Q51803667 | ||
| Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. | Q52552851 | ||
| Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. | Q54677737 | ||
| Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. | Q54787534 | ||
| Cellular heterogeneity in lymphangiomyomatosis of the lung | Q57290475 | ||
| Lymphangioleiomyomatosis | Q64047395 | ||
| Lymphangioleiomyomatosis: recurrence after single lung transplantation | Q64050175 | ||
| Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis | Q79269840 | ||
| The LAM cell: what is it, where does it come from, and why does it grow? | Q79740924 | ||
| Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis | Q80027046 | ||
| Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis | Q80337804 | ||
| Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes | Q80413685 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1765–1778 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition | |
| P478 | volume | 177 |
| Q36094125 | Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway |
| Q34032612 | Adhesion molecule periplakin is involved in cellular movement and attachment in pharyngeal squamous cancer cells |
| Q92811815 | Allosteric and ATP-Competitive Inhibitors of mTOR Effectively Suppress Tumor Progression-Associated Epithelial-Mesenchymal Transition in the Kidneys of Tsc2+/- Mice |
| Q42043023 | Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin |
| Q35074335 | Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis. |
| Q27853392 | Comprehensive mutation profiling of mucinous gastric carcinoma |
| Q38728565 | Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog |
| Q40979051 | Distinct subcellular localization of E-cadherin between epithelioid angiomyolipoma and triphasic angiomyolipoma: A preliminary case-control study |
| Q37397803 | EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS. |
| Q30578909 | Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK. |
| Q51464724 | Hepatic epithelioid angiomyolipoma with trabecular growth pattern: a mimic of hepatocellular carcinoma on fine needle aspiration cytology. |
| Q93000511 | Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy |
| Q45225843 | Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential? |
| Q58781236 | Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment |
| Q37611713 | Needs and Requirements of Modern Biobanks on the Example of Dystonia Syndromes |
| Q37641575 | Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2 |
| Q37153672 | Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy. |
| Q37417526 | Proapoptotic protein Bim attenuates estrogen-enhanced survival in lymphangioleiomyomatosis |
| Q64092570 | Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells |
| Q34408059 | Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis. |
| Q49787954 | Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulin |
| Q38410919 | Renal epithelioid angiomyolipoma: Histopathologic review, immunohistochemical evaluation and prognostic significance |
| Q36977335 | Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis |
| Q37691961 | SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis |
| Q39298534 | Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells (Panc-1). |
| Q36737131 | TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis |
| Q33991599 | TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival |
| Q39233165 | Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. |
| Q34569989 | The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis |
| Q34334448 | Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients |
| Q38942065 | WAVE3 promotes epithelial-mesenchymal transition of gastric cancer through upregulation of Snail |
| Q96683535 | mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division |
Search more.